Description
Itraconazole is a triazole antifungal agent prescribed to patients with fungal infections. The drug may be given orally or intravenously.
| Chemical Name | Itraconazole |
| Synonyms | (+/-)-4-[4-[4-[4-[[(2R,4S)-(2,4-Dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-1-piperazinyl]phenyl]-2,4-dihydro-2-(1-methylpropyl)-3H-1,2,4-triazol-3-one; Itrizole; Oriconazole; R-51211; Sporamelt; Sporanox; Triasporin; |
| CAS Number | 84625-61-6 |
| Molecular Formula | C₃₅H₃₈Cl₂N₈O₄ |
| Appearance | White to Off-White Solid |
| Melting Point | 164-166°C |
| Molecular Weight | 705.63 |
| Storage | -20°C |
| Solubility | Acetonitrile (Slightly, Heated), Chloroform (Slightly), Methanol (Slightly, Heat |
| Category | Standards; Pharmaceutical/API Drug Impurities/Metabolites; |
| Applications | Itraconazole is an orally active antimycotic structurally related to Ketoconazole. Antifungal. It is a COVID19-related research product. |
Packaging details:
| Packaging details: | 25kg/drum with double plastic bags inside; packed in a cardboard drum or fiber HDPE drum. |
| Storage: | Stored in a clean, cool, dry area; keep away from moisture and strong, direct light/heat |
